Literature DB >> 24833186

Keyhole limpet haemocyanin - a model antigen for human immunotoxicological studies.

Ashwin Swaminathan1, Robyn M Lucas, Keith Dear, Anthony J McMichael.   

Abstract

Immunization with a T-cell dependent antigen has been promoted as a reliable and sensitive tool for assessing the influence of putative immunotoxic exposures or agents on immune function. Keyhole limpet haemocyanin (KLH) is a very large, copper-containing protein molecule derived from the haemolymph of the inedible mollusc, Megathura crenulata. KLH is a highly immunogenic T-cell dependent antigen that is used increasingly in immunotoxicological studies, particularly in those involving animals. This report systematically reviews the human clinical studies that have used trans-cutaneous KLH immunization for assessment of the influence of various physiological and disease states and exposures on immune function over the last 20 years (1994-2013). These studies varied in their immunization protocols, formulation of KLH, dose, site and route of administration and immunoassay platforms developed to assess KLH-specific responses. KLH immunization has been well tolerated with only mild to moderate adverse effects reported. Though very promising as a model antigen candidate in immunotoxicology research, more work on standardizing immunization and immunoassay protocols is required.
© 2014 The British Pharmacological Society.

Entities:  

Keywords:  KLH; clinical studies; immunization; immunotoxicology; keyhole limpet haemocyanin

Mesh:

Substances:

Year:  2014        PMID: 24833186      PMCID: PMC4243888          DOI: 10.1111/bcp.12422

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  46 in total

1.  IMMUNOCHEMICAL PROPERTIES OF HEMOCYANIN.

Authors:  W O WEIGLE
Journal:  Immunochemistry       Date:  1964-12

Review 2.  Current and new strategies in immunotherapy for superficial bladder cancer.

Authors:  Frank G E Perabo; Stefan C Müller
Journal:  Urology       Date:  2004-09       Impact factor: 2.649

3.  Anaphylaxis to grand keyhole limpet (abalone-like shellfish) and abalone.

Authors:  A Morikawa; M Kato; K Tokuyama; T Kuroume; M Minoshima; S Iwata
Journal:  Ann Allergy       Date:  1990-11

4.  The use of oil adjuvants in therapeutic vaccines.

Authors:  Jerome Aucouturier; Stephane Ascarateil; Laurent Dupuis
Journal:  Vaccine       Date:  2006-04-12       Impact factor: 3.641

Review 5.  Breast cancer vaccines: a clinical reality or fairy tale?

Authors:  G Curigliano; G Spitaleri; E Pietri; M Rescigno; F de Braud; A Cardillo; E Munzone; A Rocca; G Bonizzi; V Brichard; L Orlando; A Goldhirsch
Journal:  Ann Oncol       Date:  2005-11-17       Impact factor: 32.976

6.  Human immune responses in vivo to protein (KLH) and polysaccharide (DNP-Ficoll) neoantigens: normal subjects compared with bone marrow transplant patients on cyclosporine.

Authors:  P L Amlot; A E Hayes; D Gray; E C Gordon-Smith; J H Humphrey
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

7.  Rituximab treatment results in impaired secondary humoral immune responsiveness.

Authors:  Lizet E van der Kolk; Joke W Baars; Martin H Prins; Marinus H J van Oers
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

8.  Intracutaneous and intravesical immunotherapy with keyhole limpet hemocyanin compared with intravesical mitomycin in patients with non-muscle-invasive bladder cancer: results from a prospective randomized phase III trial.

Authors:  Rianne J M Lammers; Wim P J Witjes; Maria H D Janzing-Pastors; Christien T M Caris; J Alfred Witjes
Journal:  J Clin Oncol       Date:  2012-05-14       Impact factor: 44.544

9.  Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.

Authors:  Clifton O Bingham; R John Looney; Atul Deodhar; Neal Halsey; Maria Greenwald; Christine Codding; Benjamin Trzaskoma; Flavius Martin; Sunil Agarwal; Ariella Kelman
Journal:  Arthritis Rheum       Date:  2010-01

10.  Humoral immune response to keyhole limpet haemocyanin, the protein carrier in cancer vaccines.

Authors:  A Kantele; M P Häkkinen; J Zivny; C O Elson; J Mestecky; J M Kantele
Journal:  Clin Dev Immunol       Date:  2011-06-12
View more
  22 in total

1.  Alpha-1 Antitrypsin-Expressing Mesenchymal Stromal Cells Confer a Long-Term Survival Benefit in a Mouse Model of Lethal GvHD.

Authors:  Sabine Geiger; Emrah I Ozay; Ulf Geumann; Marina K Hereth; Terese Magnusson; Sudarvili Shanthalingam; Daniela Hirsch; Stefanie Kälin; Christine Günther; Barbara A Osborne; Gregory N Tew; Felix G Hermann; Lisa M Minter
Journal:  Mol Ther       Date:  2019-05-16       Impact factor: 11.454

Review 2.  Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae.

Authors:  Kosuke Kataoka; Yoshiko Fukuyama; David E Briles; Tatsuro Miyake; Kohtaro Fujihashi
Journal:  Microbiol Immunol       Date:  2017-06       Impact factor: 1.955

3.  Monoclonal Antibodies Generation: Updates and Protocols on Hybridoma Technology.

Authors:  Ahmed Muhsin; Roberto Rangel; Long Vien; Laura Bover
Journal:  Methods Mol Biol       Date:  2022

4.  A humanized minipig model for the toxicological testing of therapeutic recombinant antibodies.

Authors:  Tatiana Flisikowska; Jerome Egli; Angelika Schnieke; Antonio Iglesias; Krzysztof Flisikowski; Marlene Stumbaum; Erich Küng; Martin Ebeling; Roland Schmucki; Guy Georges; Thomas Singer; Mayuko Kurome; Barbara Kessler; Valeri Zakhartchenko; Eckhard Wolf; Felix Weber
Journal:  Nat Biomed Eng       Date:  2022-09-22       Impact factor: 29.234

5.  Pre-clinical safety and toxicology profile of a candidate vaccine to treat oxycodone use disorder.

Authors:  Fatima A Hamid; Cheryl L Marker; Michael D Raleigh; Aaron Khaimraj; Scott Winston; Paul R Pentel; Marco Pravetoni
Journal:  Vaccine       Date:  2022-04-22       Impact factor: 4.169

6.  TCPro: an In Silico Risk Assessment Tool for Biotherapeutic Protein Immunogenicity.

Authors:  Osman N Yogurtcu; Zuben E Sauna; Joseph R McGill; Million A Tegenge; Hong Yang
Journal:  AAPS J       Date:  2019-08-02       Impact factor: 4.009

7.  Monitoring of dynamic changes in Keyhole Limpet Hemocyanin (KLH)-specific B cells in KLH-vaccinated cancer patients.

Authors:  Florian Wimmers; Nienke de Haas; Anja Scholzen; Gerty Schreibelt; Elles Simonetti; Marc J Eleveld; Huberdina M L M Brouwers; Marjo Beldhuis-Valkis; Irma Joosten; Marien I de Jonge; Winald R Gerritsen; I Jolanda M de Vries; Dimitri A Diavatopoulos; Joannes F M Jacobs
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

8.  Immunotherapeutic Potential of Mollusk Hemocyanins in Combination with Human Vaccine Adjuvants in Murine Models of Oral Cancer.

Authors:  Juan José Mora Román; Miguel Del Campo; Javiera Villar; Francesca Paolini; Gianfranca Curzio; Aldo Venuti; Lilian Jara; Jorge Ferreira; Paola Murgas; Alvaro Lladser; Augusto Manubens; María Inés Becker
Journal:  J Immunol Res       Date:  2019-01-20       Impact factor: 4.818

9.  Immune Profile of the Nasal Mucosa in Patients with Cutaneous Leishmaniasis.

Authors:  María J Gómez-Zafra; Adriana Navas; Jimena Jojoa; Julieth Murillo; Camila González; María Adelaida Gómez
Journal:  Infect Immun       Date:  2020-04-20       Impact factor: 3.609

10.  Immunization enhances the natural antibody repertoire.

Authors:  Dylan Beinart; Daniel Ren; Cinthia Pi; Susan Poulton; Zoie E Holzknecht; Chelsea Swanson; William Parker
Journal:  EXCLI J       Date:  2017-07-10       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.